What is the Pritchard regimen for treating severe malaria in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Pritchard Regimen for Severe Malaria in Pregnancy

The Pritchard regimen is not a standard treatment protocol for severe malaria in pregnancy. Instead, intravenous artesunate is the first-line treatment for severe malaria in pregnancy, as recommended by current guidelines.

Current Treatment Recommendations for Severe Malaria in Pregnancy

First-Line Treatment

  • Intravenous artesunate is the treatment of choice for severe Plasmodium falciparum infections in pregnancy 1
  • This recommendation applies across all trimesters of pregnancy

Alternative Treatments

  • Quinine-based regimens were historically used but are no longer first-line therapy due to:
    • Lower efficacy compared to artesunate-based treatments
    • Higher rates of side effects including hypoglycemia and hyperinsulinemia 2
    • Potential for complications during labor 3

Treatment Protocol for Severe Malaria in Pregnancy

Initial Management

  1. Confirm diagnosis through microscopy (gold standard) or rapid diagnostic tests
  2. Assess severity by evaluating:
    • Level of consciousness
    • Respiratory status
    • Parasitemia percentage (>5% indicates severe disease)
    • Presence of organ dysfunction

Medication Administration

  • Intravenous artesunate: Administer as per WHO guidelines 1
  • Monitor closely for:
    • Parasitemia every 12 hours until <1%, then every 24 hours until negative 1
    • Post-artesunate delayed hemolysis (PADH) at days 7,14,21, and 28 1
    • Maternal glucose levels (hypoglycemia is a common complication)
    • Fetal heart rate and signs of distress

Transition to Oral Therapy

  • Once the patient can tolerate oral medication and clinical improvement is observed, transition to oral artemisinin-based combination therapy (ACT)
  • Complete the full course of treatment

Special Considerations in Pregnancy

Maternal Monitoring

  • Hypoglycemia risk: More common in pregnant women with severe malaria, especially with quinine treatment 2
  • Fluid balance: Careful monitoring to prevent pulmonary edema

Fetal Monitoring

  • Regular assessment of fetal heart rate
  • Monitor for signs of fetal distress, which may improve as maternal condition improves 2

Delivery Considerations

  • Severe malaria is not an automatic indication for cesarean section
  • Mode of delivery should be based on obstetric indications 3

Common Pitfalls to Avoid

  • Delayed treatment: Severe malaria in pregnancy is a medical emergency requiring immediate treatment
  • Inadequate monitoring: Failure to monitor for hypoglycemia and other complications
  • Inappropriate dosing: Dosing should be weight-based and not reduced due to pregnancy
  • Incomplete treatment: Ensure full course of therapy is completed

The evidence clearly demonstrates that artemisinin-based therapies are superior to quinine-based regimens for treating severe malaria in pregnancy, with higher cure rates and fewer adverse effects 4, 1. The historical practice of using quinine regimens has been superseded by more effective and safer artemisinin-based treatments.

References

Guideline

Malaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Quinine and severe falciparum malaria in late pregnancy.

Lancet (London, England), 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.